InvestorsHub Logo
Followers 240
Posts 12423
Boards Moderated 0
Alias Born 08/14/2003

Re: Mikems post# 34879

Tuesday, 05/12/2020 3:31:10 PM

Tuesday, May 12, 2020 3:31:10 PM

Post# of 44784
I took my eyes off the stock for a few minutes and the gain for the day nearly doubled. I've got to believe that someone knows something that hasn't yet been stated by the company. We know there are more than 7 compassionate use patients, yet they're all the company has chosen to speak about. I cannot say when, or if the company will bring us up to date on what's been shown in the compassionate dose cases, or is all they report on the status of the Phase 2 Trial.

It's very possible some to receive the drug have passed on, it's practically impossible to cure all who've been hit with the disease. Many of those on ventilators have serious health conditions before ever getting covid-19. I believe anything that saves 50% or more of ventilator patients would be considered nearly a miracle, and thus far we're doing much better than that.

I really wish we could see what happens when the drug is given to newly diagnosed pneumonia patients, but that won't happen until it's been tried on those who're much sicker. I'm of the believe that a lighter dose in a healthier patient may be all that's needed to quickly cure the pneumonia. I don't know how many patients might be treated with a single vial of the medicine, but even if it's just a few, it would greatly lower the cost, and keeping people out of the hospital would certainly prove cost effective.

Gary